Patheon Softgels Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PATHEON SOFTGELS, and what generic and branded alternatives to PATHEON SOFTGELS drugs are available?
PATHEON SOFTGELS has two approved drugs.
Summary for Patheon Softgels
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Patheon Softgels
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patheon Softgels | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 214463-001 | Jan 10, 2023 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Patheon Softgels | IBUPROFEN | ibuprofen | CAPSULE;ORAL | 217236-001 | Feb 13, 2024 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
